ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,697.50
-7.50 (-0.44%)
Last Updated: 09:05:51
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.50 -0.44% 1,697.50 1,697.00 1,697.50 1,711.00 1,695.50 1,705.00 456,657 09:05:51
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.22 70.07B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,705p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.07 billion. Gsk has a price to earnings ratio (PE ratio) of 14.22.

Gsk Share Discussion Threads

Showing 21201 to 21225 of 33125 messages
Chat Pages: Latest  857  856  855  854  853  852  851  850  849  848  847  846  Older
DateSubjectAuthorDiscuss
30/4/2020
17:37
Riz,

Agree with Spud plus AZN now hugely overbought. May tumble tomorrow and come back to the 20 DMA.

beckers2008
30/4/2020
17:35
I read here that AZN and GSK were both together in the discovery of the corona virus Vaccine?
abdullla
30/4/2020
17:29
Imo, no. All the value and then some is in it. It's p/e is more than 5x GSK. Plus the dividend is 50% less. spud
spud
30/4/2020
17:22
Is it worth buying into azn?
riz000
30/4/2020
17:18
Not really surprised by the price action today. Decent results but the excitement and sentiment is elsewhere such as AZN.Does anyone remember when the demerger was slotted to happen?
rikky72
30/4/2020
17:12
Market manipulation is the game.
abdullla
30/4/2020
17:01
Looked good at 2-30pm today rising 23p, then started to tumble very quickly! Difficult to understand why both of these trends occurred in such a short space of time.
jadeticl3
30/4/2020
16:27
AZN is flying after it admits that it has joined Oxford university to develop vaccine ready for use at the end of this year,this is world's first,BBC news now.
abdullla
30/4/2020
15:59
Sellers always above 1700p. Had a great run, no harm profit taking, AstraZeneca is the one way over bought.
montyhedge
30/4/2020
15:13
Inverse H&S?

Buy at 1575 target 1775?

toffeeman
30/4/2020
15:09
>1700p proving to be a bit of a struggle …. ;0)
tradermichael
30/4/2020
15:00
It’s perhaps not surprising that the worth of healthcare companies should emerge during a global pandemic, but we should offer thanks for the UK’s big pharma twins – AstraZeneca and GlaxoSmithKline (continued) ....
zho
30/4/2020
14:56
Looking at the so far pharma results it's quite clear that they are better than previous ones which proves that the drastic drop in the share price was unwarranted,the recent daily rises supports this factor.
abdullla
30/4/2020
12:28
Yes TM free of COST but if you read between the lines you will find pumped up administration and manufacturing costs also.
abdullla
30/4/2020
12:04
Not necessarily: Soriot also said there is agreement between companies within the pharmaceutical industry to help one another with production, and that the intention is to supply the vaccine free of charge during the pandemic.
tradermichael
30/4/2020
10:59
AZN will fly with Oxford invented vaccine the reason behind the rise,"Astra possibly to manufacture and sell the Oxford University vaccine if it looks promising"
abdullla
30/4/2020
10:12
Come GSK pull your finger out.... AZN keeps hitting ATH even though its on a much bigger p/e and lower growth rate than GSK.
igoe104
30/4/2020
09:50
This is rather frustrating.
eggy toast
30/4/2020
09:25
AZN flying GSK finding it difficult to stay afloat why?
abdullla
30/4/2020
09:07
FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status
-- Zejula is the only oral monotherapy available as first-line maintenance treatment for women regardless of BRCA mutational status, addressing a high unmet need in ovarian cancer
-- New individualised starting dose based on the patient's baseline weight and/or platelet count approved for first-line maintenance treatment; lower rates of haematological adverse events were observed with the individualised dosing group

tradermichael
29/4/2020
20:32
Vaccine worry on sales. Perhaps that why they are down.https://www.fiercepharma.com/pharma/glaxosmithkline-fields-worries-about-shingrix-demand-as-covid-19-halts-routine-doc-visits
montyhedge
29/4/2020
19:33
Let's hope they have terrible results, share price tends rise then.
waikenchan
29/4/2020
17:43
Guys keep an eye on Barclays, RBS and lloyds are my bet,
riz000
29/4/2020
17:36
Bloomberg reports that GlaxoSmithKline (NYSE:GSK) plans to sell its 5.7% stake in Hindustan Unilever Ltd. (NYSE:UL) via a series of block trades totaling $3.7B.

The company received the equity this week as part of the payment for a recently completed sale of a portfolio of assets to Unilever that included health food drink brands in India and Bangladesh for $3.6B in cash plus the Hindustan stake.

The precise timing of the sales has not been disclosed.

philanderer
29/4/2020
16:41
My roof is leaking on close examination found GSK had gone through the roof !lol
abdullla
Chat Pages: Latest  857  856  855  854  853  852  851  850  849  848  847  846  Older

Your Recent History

Delayed Upgrade Clock